When acting as a ligand, it binds to PSGL-1 and VSIG-3 on T cells, especially under acidic pH conditions of the tumor microenvironment, delivering a suppressive signal that reduces T cell proliferation and cytokine production. Here, IGSF11 is linked to neoplasm.